S. Schifano

Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review

V. Adamo, G. Ricciardi, T. Franchina, 2018, BMC Cancer.

The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy.

V. Adamo, G. Toscano, A. Battaglia, 2018, Critical reviews in oncology/hematology.

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

V. Adamo, G. Ricciardi, T. Franchina, 2016, OncoTargets and therapy.

Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review

V. Adamo, G. Ricciardi, T. Franchina, 2018, BMC Cancer.

Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience

S. Molica, A. Frustaci, M. Caira, 2023, Hematological oncology.